A detailed history of Innovis Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Innovis Asset Management LLC holds 5,248 shares of BMY stock, worth $300,867. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,248
Previous 5,158 1.74%
Holding current value
$300,867
Previous $330 Million 7.66%
% of portfolio
0.12%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$57.89 - $64.73 $5,210 - $5,825
90 Added 1.74%
5,248 $305 Million
Q2 2023

Aug 03, 2023

SELL
$63.71 - $70.74 $3,312 - $3,678
-52 Reduced 1.0%
5,158 $330 Million
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $2,431 - $2,757
37 Added 0.72%
5,210 $361 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $354,247 - $419,478
5,173 New
5,173 $372 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Innovis Asset Management LLC Portfolio

Follow Innovis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innovis Asset Management LLC with notifications on news.